AstraZeneca is a Global Biopharmaceutical Company with Research and Development at its Core. The global healthcare environment is changing at a rapid pace. Healthcare is becoming more personalized, treatments are becoming more targeted, and economic pressures mean governments and healthcare systems are demanding increasingly cost-effective solutions to healthcare problems. Our ultimate mission is to make a difference through our medicines for patients, their families and society in general. We believe that scientific research is the key to achieving this, in collaboration with others who share our interest and our passion.

View the latest AstraZeneca Challenges

Our Open Innovation Goals and Resources Available

Although AstraZeneca has extensive expertise in biopharmaceutical research and development, we recognize that great ideas come from many sources. In fact, most biomedical innovation occurs outside company walls. Thus, we believe that we stand a much better chance of delivering meaningful treatments for serious diseases like Alzheimer’s, cancer and diabetes if we collaborate and share knowledge and resources with other scientists and organizations rather than work in isolation.

You are invited to view and participate in our Challenges, please click on the Challenges tab for more information. In addition to the open innovation Challenges, we are seeking to collaborate with partners across all stages of drug discovery – from the early idea through to early clinical development. These partnerships could profit from the exchange of compounds, technology and/or knowledge to provide an extra gear to hasten and augment the research. For our partners and collaborators, working with AstraZeneca means access to optimized compounds, compound libraries, technologies, multi-disciplinary science, services and know-how, with the prospect of joint publications in high profile journals and, most importantly, the opportunity to see their ideas develop into treatments for patients.

Here's how the Challenge process works:


Sign up and complete your Solver profile

Review & Accept

Read the description of the Open Challenges in the Challenge Center and accept the Challenge Agreement


Upload proposed solution(s) you have developed for a specific Challenge


Receive cash awards for solutions accepted by Seeker organizations

Collaboration Update

In 2011, a novel agreement between the Medical Research Council (MRC) and AstraZeneca gave academic researchers across the UK unprecedented access to 22 of our clinical and preclinical compounds.
Visit AstraZeneca to learn more